免疫性血小板减少性紫癜的临床试验
总计51264个结果
-
Etablissement Français du SangUniversity Hospital, Grenoble完全的
-
Massachusetts General HospitalBristol-Myers Squibb终止
-
Singapore General HospitalDSO National Laboratories; Health Sciences Authority, Singapore完全的
-
Henri Mondor University HospitalAmgen; Paris 12 Val de Marne University完全的
-
Jiangsu HengRui Medicine Co., Ltd.撤销
-
Xinqiao Hospital of ChongqingPeking University First Hospital; LanZhou University; RenJi Hospital; Qilu Hospital of Shandong... 和其他合作者未知新生儿同种免疫性血小板减少症
-
University of BergenHaukeland University Hospital完全的
-
The First Affiliated Hospital of Zhengzhou UniversityJiangsu HengRui Medicine Co., Ltd.尚未招聘肿瘤治疗相关的血小板减少症
-
Sichuan Clover Biopharmaceuticals, Inc.招聘中
-
Jena University HospitalMedical University of Vienna; Hannover Medical School; University Hospital, Essen; University Hospital... 和其他合作者完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘化疗引起的血小板减少症
-
Amgen完全的癌症 | 霍奇金淋巴瘤 | 非霍奇金淋巴瘤 | 血小板减少症 | 肿瘤学 | 化疗引起的血小板减少症
-
The First Affiliated Hospital of Soochow University尚未招聘
-
Karolinska InstitutetHarvard Medical School (HMS and HSDM); Karolinska University Hospital; National Heart, Lung, and... 和其他合作者招聘中
-
Centre Hospitalier Universitaire de Saint EtienneSanofi; Hyphen BioMed; CIC-EC de Saint-Etienne; Groupe d'étude sur l'Hémostase et la Thrombose; Association... 和其他合作者完全的
-
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion...Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Leiden University Medical...完全的脑室内出血 | 新生儿血小板减少症 | 血小板输注
-
Assistance Publique - Hôpitaux de Paris完全的
-
The University of Texas Health Science Center,...GlaxoSmithKline完全的
-
Canyon Pharmaceuticals, Inc.终止
-
Shanghai Children's Medical CenterXiamen Amoytop Biotech Co., Ltd.完全的
-
Boston Children's HospitalNational Heart, Lung, and Blood Institute (NHLBI); Beth Israel Deaconess Medical Center招聘中
-
The Medicines Company撤销
-
University of LouisvilleJames Graham Brown Cancer Center终止
-
Karyopharm Therapeutics Inc招聘中
-
Ministry of Health, Labour and Welfare, JapanMitsubishi Tanabe Pharma Corporation完全的
-
Terumo BCTbioBiomedical Advanced Research and Development Authority终止